UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2546-2552

1997

Volltextzugriff (PDF)

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1098-1105

1996

Volltextzugriff (PDF)

Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2546-2552

1999

Volltextzugriff (PDF)

Paclitaxel, Estramustine Phosphate, and Carboplatin in Patients With Advanced Prostate Cancer

Journal of clinical oncology, 2001-01, Vol.19 (1), p.44-53

2001

Volltextzugriff (PDF)

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2559-2563

1997

Volltextzugriff (PDF)

Spécificités moléculaires des tumeurs de la voie excrétrice urinaire supérieure

Progrès en urologie (Paris), 2018-11, Vol.28 (13), p.680-681

2018

Volltextzugriff (PDF)

Classification phylogénétique des récidives vésicales après tumeur de la voie excrétrice urinaire supérieure

Progrès en urologie (Paris), 2018-11, Vol.28 (13), p.681-681

2018

Volltextzugriff (PDF)

Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design

Clinical genitourinary cancer, 2015-02, Vol.13 (1), p.71-79

2015

Volltextzugriff (PDF)

Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update

Urology (Ridgewood, N.J.), 2011-03, Vol.77 (3), p.655-659

2011

Volltextzugriff (PDF)

Low-Volume Nodal Metastases Detected at Retroperitoneal Lymphadenectomy for Testicular Cancer: Pattern and Prognostic Factors for Relapse

Journal of clinical oncology, 2001-04, Vol.19 (7), p.2020-2025

2001

Volltextzugriff (PDF)

Recommendations for a Global Core Curriculum in Medical Oncology

Annals of oncology, 2004-11, Vol.15 (11), p.1603-1612

2004

Volltextzugriff (PDF)

POST-CHEMOTHERAPY SURGERY IN PATIENTS WITH UNRESECTABLE OR REGIONALLY METASTATIC BLADDER CANCER

The Journal of urology, 2001-03, Vol.165 (3), p.811-814

2001

Volltextzugriff (PDF)

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

Journal of clinical oncology, 1995-06, Vol.13 (6), p.1384-1390

1995

Volltextzugriff (PDF)

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center

Journal of clinical oncology, 1996-02, Vol.14 (2), p.454-460

1996

Volltextzugriff (PDF)

Phase iii randomized trial of interleukin‐2 with or without lymphokine‐activated killer cells in the treatment of patients with advanced renal cell carcinoma

Cancer, 1995-09, Vol.76 (5), p.824-832

1995

Volltextzugriff (PDF)

Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract : Final report of a phase II trial evaluating two dosing schedules

Cancer, 2000-04, Vol.88 (7), p.1671-1678

2000

Volltextzugriff (PDF)

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

Journal of clinical oncology, 1993-04, Vol.11 (4), p.598-606

1993

Volltextzugriff (PDF)

Surgery for a Post-Chemotherapy Residual Mass in Seminoma

The Journal of urology, 1997-03, Vol.157 (3), p.860-862

1997

Volltextzugriff (PDF)

Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2722-2727

1998

Volltextzugriff (PDF)

Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer

Journal of clinical oncology, 2001-09, Vol.19 (18), p.17s-20s

BAJORIN, Dean F

2001

Volltextzugriff (PDF)

Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors

JNCI : Journal of the National Cancer Institute, 1993-11, Vol.85 (22), p.1828-1835

1993

Volltextzugriff (PDF)

2003P Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression

Annals of oncology, 2024-09, Vol.35, p.S1157-S1158

2024

Volltextzugriff (PDF)

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6549-6555

2005

Volltextzugriff (PDF)

Acute Nonlymphocytic Leukemia in Germ Cell Tumor Patients Treated With Etoposide-Containing Chemotherapy

JNCI : Journal of the National Cancer Institute, 1993-01, Vol.85 (1), p.60-62

1993

Volltextzugriff (PDF)

Toxicology and Pharmacokinetics of Intravesical Gemcitabine: A Preclinical Study in Dogs

Clinical cancer research, 1999-09, Vol.5 (9), p.2629-2637

1999

Volltextzugriff (PDF)

26 – 50 von 381

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(307)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(199)
Science & Technology
(191)
Life Sciences & Biomedicine
(185)
Oncology
(141)
Male
(132)
Biological And Medical Sciences
(115)
Medical Sciences
(115)
Middle Aged
(101)
Adult
(98)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(82)
Female
(79)
Aged
(72)
Pharmacology. Drug Treatments
(71)
Antineoplastic Agents
(66)
Chemotherapy
(66)
Tumors
(52)
Cisplatin - Administration & Dosage
(49)
Treatment Outcome
(45)
Urinary Bladder Neoplasms - Drug Therapy
(42)
Prognosis
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity

Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma

Paclitaxel, Estramustine Phosphate, and Carboplatin in Patients With Advanced Prostate Cancer

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival

Spécificités moléculaires des tumeurs de la voie excrétrice urinaire supérieure

Classification phylogénétique des récidives vésicales après tumeur de la voie excrétrice urinaire supérieure

Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design

Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update

Low-Volume Nodal Metastases Detected at Retroperitoneal Lymphadenectomy for Testicular Cancer: Pattern and Prognostic Factors for Relapse

Recommendations for a Global Core Curriculum in Medical Oncology

POST-CHEMOTHERAPY SURGERY IN PATIENTS WITH UNRESECTABLE OR REGIONALLY METASTATIC BLADDER CANCER

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center

Phase iii randomized trial of interleukin‐2 with or without lymphokine‐activated killer cells in the treatment of patients with advanced renal cell carcinoma

Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract : Final report of a phase II trial evaluating two dosing schedules

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

Surgery for a Post-Chemotherapy Residual Mass in Seminoma

Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial

Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer

Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors

2003P Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Acute Nonlymphocytic Leukemia in Germ Cell Tumor Patients Treated With Etoposide-Containing Chemotherapy

Toxicology and Pharmacokinetics of Intravesical Gemcitabine: A Preclinical Study in Dogs

Suchergebnisse filtern